Tenfold Increase of Manufacturing Capacities in 2022. The new headquarters of the biotech company can thus increase from 50 to 90 employees.
The technology hotspot in aspern Urban Lakeside continues to grow: Biomay, a Vienna-based biotech company, is constructing a new production facility which will increase its manufacturing capacities tenfold and its headcount almost twofold. The new headquarters in aspern Seestadt, Vienna, will go into operation in Q1/2022. The Vienna Business Agency supported Biomay in finding a location and with several grants, most recently as part of the location initiative.
The ground-breaking ceremony for the new Biomay HQ took place in September 2020, with construction work starting immediately afterwards. The new site will nearly double Biomay’s headcount, from 50 at present to 90 going forward.
The fully integrated manufacturing plant comprises a total floor area of about 4000 square meters (43 000 sq ft) and will be equipped with state-of-the-art facilities for the manufacturing of innovative biopharmaceutical products. A dedicated area of the new building will allow the parallel production of innovative, personalized batches.
Vienna, 18 December 2020